Technical Analysis for SURF - Surface Oncology, Inc.

Grade Last Price % Change Price Change
grade D 1.62 -6.36% -0.11
SURF closed down 6.36 percent on Monday, November 11, 2019, on approximately normal volume. It was able to find support at its 50 day moving average.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Flat Down
See historical SURF trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Wide Bands Range Expansion 0.00%
New Uptrend Bullish -6.36%
180 Bullish Setup Bullish Swing Setup -6.36%
Upper Bollinger Band Walk Strength -6.36%
Wide Bands Range Expansion -6.36%
Overbought Stochastic Strength -6.36%
Shooting Star Candlestick Bearish -4.71%
Lizard Bearish Bearish Day Trade Setup -4.71%
Doji - Bearish? Reversal -4.71%

Older signals for SURF ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
SURF Chart by TradingView
Basic chart:
Profile
Surface Oncology is a clinical-stage immuno-oncology company developing next-generation antibody therapies focused on the tumor microenvironment with lead programs targeting CD47 and CD73. Surface’s novel cancer immunotherapies are designed to achieve a clinically meaningful and sustained anti-tumor response, alone or in combination with other therapies. The company has a pipeline of immunotherapies and a strategic collaboration with Novartis focused on up to three next-generation cancer immunotherapies.
Medicine Medical Specialties Clinical Medicine Immunotherapy Cancer Treatments Tumor Virotherapy Cancer Immunotherapy Immunotherapies Cancer Research CD47 Active Immunotherapy Next Generation Cancer Novel Cancer
Is SURF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Nov 7 Surface Oncology Presents Updates at the Society for Immunotherapy of Cancer’s Annual Meeting
Oct 26 Kaskela Law LLC Announces Investigation of Surface Oncology, Inc. on Behalf of Investors - SURF
Oct 7 Surface Oncology to Host Analyst and Investor Day on November 18, 2019 in New York City
Oct 2 AIMT, AYI, NIO and TSG among midday movers
Oct 2 The Daily Biotech Pulse: J&J Settles Ohio Opioid Lawsuit, Teligent Explores Options For Certain Assets, Novartis Reports Cosentyx Data
Sep 27 ENDP, INMD, LTM and NXTC among midday movers
Sep 27 The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave
Sep 26 The Daily Biotech Pulse: Enanta Aces Midstage NASH Study, Takeda's Ulcerative Colitis Drug Found Superior To AbbVie's, Decision Day For J&J
Sep 25 Stocks That Hit 52-Week Lows On Wednesday
Sep 23 Here's Why Surface Oncology (NASDAQ:SURF) Must Use Its Cash Wisely
See more SURF news...
Indicators
Indicator Value
52 Week High 9.94
52 Week Low 1.15
Average Volume 64,227
200-Day Moving Average 3.2069
50-Day Moving Average 1.6156
20-Day Moving Average 1.511
10-Day Moving Average 1.646
Average True Range 0.1129
ADX 25.6
+DI 27.091
-DI 15.7156
Chandelier Exit (Long, 3 ATRs ) 1.5113
Chandelier Exit (Short, 3 ATRs ) 1.5387
Upper Bollinger Band 1.8109
Lower Bollinger Band 1.2111
Percent B (%b) 0.68
BandWidth 39.695566
MACD Line 0.0472
MACD Signal Line 0.0098
MACD Histogram 0.0374
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.88
Resistance 3 (R3) 1.88 1.81 1.83
Resistance 2 (R2) 1.81 1.74 1.80 1.82
Resistance 1 (R1) 1.71 1.70 1.68 1.71 1.80
Pivot Point 1.64 1.64 1.62 1.63 1.64
Support 1 (S1) 1.54 1.57 1.51 1.54 1.44
Support 2 (S2) 1.47 1.53 1.46 1.42
Support 3 (S3) 1.37 1.47 1.41
Support 4 (S4) 1.37